Related Experiment Videos

Plasma fibronectin-C1q complex formation and its effect on C1q inhibition of collagen-induced platelet aggregation

Thrombosis Research
|November 1, 1983
PubMed

Insights

The first component of complement (C1q) binds platelets and inhibits aggregation. This study found plasma fibronectin (Pl Fn) forms complexes with C1q, but doesn't alter C1q's effect on platelets.

Area of Science:

  • Immunology
  • Biochemistry
  • Hematology

Background:

  • The first component of complement (C1q) possesses a collagen-like structure.
  • C1q is known to bind platelets and inhibit collagen-induced platelet aggregation.
  • Plasma fibronectin (Pl Fn) is a key protein in the extracellular matrix and plasma.

Purpose of the Study:

  • To investigate the interactions among C1q, plasma fibronectin (Pl Fn), and platelets.
  • To determine if Pl Fn influences the interaction between C1q and platelets.

Main Methods:

  • Gel filtration chromatography (Sepharose 2B and 4B) was used to analyze mixtures of C1q and Pl Fn.
  • Platelet aggregation assays were performed following preincubation of components.

Main Results:

  • Evidence of complex formation between C1q and Pl Fn was observed via gel filtration.
  • Preincubation of Pl Fn with platelets did not affect collagen-induced platelet aggregation.
  • Preincubation of Pl Fn with C1q did not significantly alter C1q's inhibition of collagen-induced platelet aggregation.

Conclusions:

  • C1q and Pl Fn form complexes, suggesting a direct interaction.
  • The interaction sites of Pl Fn with C1q may differ from the interaction sites of C1q with platelets.
  • Pl Fn does not significantly interfere with C1q's inhibitory effect on collagen-induced platelet aggregation.

Related Concept Videos